Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
Increased incidence of multiple sclerosis in the Veneto region, Italy.
Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels.
Risperidone-Induced Pisa Syndrome in MS: Resolution with Lurasidone and Recurrence with Chlorpromazine.
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature.
Pivotal role of choline metabolites in remyelination.
The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
KCHO-1, a Novel Antineuroinflammatory Agent, Inhibits Lipopolysaccharide-Induced Neuroinflammatory Responses through Nrf2-Mediated Heme Oxygenase-1 Expression in Mouse BV2 Microglia Cells.
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry.
Early-onset of multiple sclerosis in a 5-year-old girl.
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
The fibrotic scar in neurological disorders.
Acute transverse myelitis in childhood: A single centre experience from North India.
Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?
Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review.
Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.
Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design.
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.
Efficacy of Fish Oil on Serum of TNF α , IL-1 β , and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b.
Present and emerging therapies for multiple sclerosis.

Pages